法明制药 PHAR
$12.29 −$0.01 (-0.08%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $12.29 0.00%
开盘$12.05
昨收$12.30
当日区间$12.05 – $12.38
成交量9,729
市值$869.86M
市盈率（TTM）37.2
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$117.56M+20.8% YoY
营业利润$27.59M+75.2% YoY
净利润$22.43M+197.1% YoY
摊薄每股收益$0.32+188.1% YoY
自由现金流$32.09M+0.4% YoY
经营现金流$32.37M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率85.1%
营业利润率6.7%
净利率6.3%
净资产收益率8.7%
资产收益率5.0%
投入资本回报率6.0%
流动比率3.23
负债/资产比率41.4%
现金及投资$189.56M
总负债$111.03M
净现金（净负债）$78.53M
自由现金流/营收8.9%
营收构成
2026/Q1 季度
按业务线
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $117.56M | $90.21M | $72.45M | $376.13M | $106.50M |
| 营业总收入 | $117.56M | $90.21M | $72.45M | $376.13M | $106.50M |
| 营业成本 | $15.36M | $14.55M | $6.64M | $45.50M | $21.10M |
| 毛利润 | $102.19M | $75.67M | $65.80M | $330.63M | $85.40M |
| 营业费用 | $74.60M | $75.78M | $71.09M | $309.75M | $83.40M |
| 销售及管理费用 | $45.03M | $43.52M | $45.53M | $117.44M | $51.30M |
| -销售及营销费用 | $29.46M | $28.57M | $30.32M | $6.66M | $31.30M |
| -管理费用 | $15.57M | $14.95M | $15.22M | $110.78M | $20.00M |
| 研发费用 | $29.57M | $32.26M | $25.56M | $100.37M | $32.10M |
| 营业利润 | $27.59M | -$111,000.00 | -$5.29M | $20.88M | $2.00M |
| 非经营性利息净收入（支出） | $6.60M | -$4.13M | $542,000.00 | -$8.74M | -$1.40M |
| 其他财务成本合计 | -$3.04M | – | – | $196,000.00 | – |
| 其他收入（支出） | -$2.94M | $7.28M | -$8,000.00 | $704,000.00 | $4.20M |
| 权益法投资收益 | $65,000.00 | $553,000.00 | -$385,000.00 | $623,000.00 | – |
| 其他非经营性收入（支出） | $2.30M | $1.42M | $377,000.00 | $1.58M | $4.20M |
| 税前利润 | $31.24M | $3.04M | -$4.75M | $12.85M | $4.80M |
| 税费 | $8.82M | $1.40M | $459,000.00 | $10.31M | -$500,000.00 |
| 净利润 | $22.43M | $1.64M | -$5.21M | $2.54M | $5.30M |
| 持续经营利润 | $22.43M | $1.64M | -$5.21M | $2.54M | $5.30M |
| 少数股东权益 | $0.00 | $0.00 | $0.00 | -$313,000.00 | – |
| 归属母公司净利润 | $22.43M | $1.64M | -$5.21M | $2.85M | $5.30M |
| 归属普通股股东净利润 | $22.43M | $1.64M | -$5.21M | $2.85M | $5.30M |
| 基本每股收益 | $0.32 | $0.02 | -$0.07 | $0.04 | $0.08 |
| 摊薄每股收益 | $0.32 | $0.02 | -$0.07 | $0.04 | $0.07 |
| 非经营性利息收入 | – | -$1.42M | $3.24M | $2.18M | – |
| 非经营性利息支出 | – | $2.68M | $2.70M | $10.72M | $1.40M |
| 折旧、摊销与折耗 | – | – | – | $9.21M | – |
| -折旧与摊销 | – | – | – | $9.21M | – |
| 其他营业费用 | – | – | – | $82.74M | – |
| 证券出售收益 | – | – | – | -$4.88M | – |
| 特殊收益（费用） | – | – | – | $3.39M | – |
| -减：资本性资产减值 | – | – | – | $491,000.00 | – |
| -减：其他特殊支出 | – | – | – | -$3.88M | – |
| -固定资产出售收益 | – | – | – | $0.00 | – |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $496.64M | $467.98M | $489.37M | $499.96M | $499.96M |
| 流动资产合计 | $322.38M | $280.69M | $295.51M | $299.47M | $299.47M |
| 现金及现金等价物与短期投资 | $189.56M | $158.28M | $170.18M | $179.10M | $179.10M |
| -现金及现金等价物 | $189.56M | $158.28M | $52.38M | $145.31M | $145.31M |
| -短期投资 | $0.00 | $0.00 | $117.80M | $33.80M | $33.80M |
| 应收款 | $74.83M | $56.98M | $60.03M | $48.44M | $48.44M |
| -应收账款 | $74.83M | $56.98M | $60.03M | $41.77M | $41.77M |
| 存货 | $57.99M | $65.43M | $64.58M | $64.90M | $64.90M |
| 受限现金 | $0.00 | $0.00 | $725,000.00 | $761,000.00 | $761,000.00 |
| 非流动资产合计 | $174.26M | $187.30M | $193.85M | $200.50M | $200.50M |
| 固定资产净值 | $19.50M | $20.48M | $23.10M | $23.97M | $23.97M |
| -固定资产原值 | $19.50M | $20.48M | $23.10M | $60.40M | $60.40M |
| 投资及预付款 | $8.59M | $8.58M | $8.11M | $8.65M | $8.65M |
| -长期股权投资 | $2.11M | $2.06M | $1.53M | $1.94M | $1.94M |
| 一年以上预付资产 | $91,000.00 | $92,000.00 | $93,000.00 | $94,000.00 | $94,000.00 |
| 商誉及其他无形资产 | $125.67M | $128.08M | $130.99M | $135.54M | $135.54M |
| 一年以上递延资产 | $19.05M | $28.84M | $30.67M | $31.02M | $31.02M |
| 其他非流动资产 | $1.36M | $1.23M | $894,000.00 | $1.23M | $1.23M |
| 负债合计 | $205.40M | $197.49M | $220.41M | $222.86M | $222.86M |
| 流动负债合计 | $99.95M | $93.25M | $112.35M | $115.79M | $115.79M |
| 应付款 | $90.07M | $82.32M | $103.53M | $14.59M | $14.59M |
| -应付账款 | $90.07M | $82.32M | $103.53M | $8.55M | $8.55M |
| 短期债务及融资租赁负债 | $9.07M | $9.05M | $8.15M | $8.71M | $8.71M |
| -一年内到期债务 | $5.58M | $5.47M | $5.38M | $5.34M | $5.34M |
| -一年内到期融资租赁负债 | $3.48M | $3.58M | $2.77M | $3.37M | $3.37M |
| 一年内预提费用 | $816,000.00 | $1.88M | $675,000.00 | $1.19M | $1.19M |
| 非流动负债合计 | $105.45M | $104.25M | $108.06M | $107.07M | $107.07M |
| 长期债务及融资租赁负债 | $105.45M | $104.25M | $108.06M | $107.07M | $107.07M |
| -长期债务 | $94.34M | $92.40M | $93.39M | $92.72M | $92.72M |
| -长期融资租赁负债 | $11.10M | $11.85M | $14.67M | $14.35M | $14.35M |
| 股东权益合计 | $291.24M | $270.49M | $268.96M | $277.10M | $277.10M |
| 股东权益 | $291.24M | $270.49M | $268.96M | $277.10M | $277.10M |
| 股本 | $8.09M | $8.08M | $8.07M | $8.01M | $8.01M |
| -普通股 | $8.09M | $8.08M | $8.07M | $8.01M | $8.01M |
| 资本公积 | $520.91M | $520.31M | $518.60M | $513.26M | $513.26M |
| 留存收益 | -$255.28M | -$278.25M | -$281.46M | -$272.98M | -$272.98M |
| 不影响留存收益的损益 | $17.52M | $20.34M | $23.75M | $28.82M | $28.82M |
| 其他非流动负债 | – | – | -$1,000.00 | – | – |
| 少数股东权益 | – | – | $0.00 | $0.00 | $0.00 |
| -应收税款 | – | – | – | $4.74M | $4.74M |
| -其他应收款 | – | – | – | $1.93M | $1.93M |
| 预付资产 | – | – | – | $6.26M | $6.26M |
| 其他流动资产 | – | – | – | $1,000.00 | $1,000.00 |
| -累计折旧 | – | – | – | -$36.43M | -$36.43M |
| -商誉 | – | – | – | $3.32M | $3.32M |
| -其他无形资产 | – | – | – | $132.22M | $132.22M |
| -应付税款合计 | – | – | – | $6.04M | $6.04M |
| 一年内应计费用 | – | – | – | $91.31M | $91.31M |
| 其他流动负债 | – | – | – | -$1,000.00 | -$1,000.00 |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | $32.37M | -$9.66M | $1.95M | $54.71M | $10.71M |
| 持续经营经营活动现金流净额 | $32.37M | -$9.66M | $1.95M | $54.71M | $10.71M |
| 持续经营净利润 | $31.24M | $3.04M | -$4.75M | $12.85M | $4.80M |
| 持续经营损益 | -$105,000.00 | -$521,000.00 | $391,000.00 | -$4.36M | -$4.63M |
| 折旧、折耗与摊销 | $2.59M | $3.04M | $3.12M | $11.22M | $3.21M |
| 其他非现金项目 | -$1.32M | -$1.18M | -$567,000.00 | $13.38M | $2.29M |
| 营运资金变动 | -$7.08M | -$18.14M | $445,000.00 | $10.39M | $1.50M |
| -应收款变动 | -$16.12M | $5.72M | -$4.40M | -$3.36M | -$14.81M |
| -存货变动 | $1.88M | -$6.99M | -$264,000.00 | -$1.29M | $4.40M |
| -应付账款及应计费用变动 | $8.36M | -$18.44M | $5.29M | $14.13M | $9.99M |
| -其他营运资金变动 | -$1.20M | $1.58M | -$181,000.00 | $902,000.00 | $1.92M |
| 投资活动现金流净额 | -$280,000.00 | -$83,000.00 | -$84.76M | $26.25M | -$45,000.00 |
| 持续经营投资活动现金流净额 | -$280,000.00 | -$83,000.00 | -$84.76M | $26.25M | -$44,000.00 |
| 资本支出 | -$280,000.00 | -$83,000.00 | -$238,000.00 | -$749,000.00 | -$269,000.00 |
| 无形资产购置及出售净额 | $0.00 | $0.00 | $0.00 | -$6,000.00 | $0.00 |
| 业务购买及出售净额 | $0.00 | $0.00 | $0.00 | -$58.22M | -$8,000.00 |
| 投资购置及出售净额 | $0.00 | $0.00 | -$84.52M | $85.22M | $233,000.00 |
| 筹资活动现金流 | -$395,000.00 | -$2.45M | -$9.22M | $1.50M | $1.04M |
| 持续经营筹资活动现金流净额 | -$395,000.00 | -$2.45M | -$9.22M | $1.50M | $1.04M |
| 债务发行及偿还净额 | -$909,000.00 | -$919,000.00 | -$12.98M | -$4.25M | -$1.37M |
| 已付现金股利 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 股票期权行使所得 | $605,000.00 | $1.22M | $3.88M | $19.81M | $5.25M |
| 期末现金余额 | $189.56M | $158.28M | $52.38M | $145.31M | $145.31M |
| 现金净变动 | $31.70M | -$12.19M | -$92.03M | $82.45M | $11.70M |
| 期初现金余额 | $158.28M | $52.38M | $145.31M | $54.94M | $132.37M |
| 汇率变动影响 | -$417,000.00 | $292,000.00 | -$895,000.00 | $7.91M | $1.24M |
| 自由现金流 | $32.09M | -$9.74M | $1.71M | $53.95M | $10.44M |
| 其他投资变动净额 | – | – | – | -$1,000.00 | – |
| 其他筹资费用净额 | – | – | – | -$7.88M | $0.00 |
暂无评论——快来第一个聊聊 PHAR。